Kaya Holdings (KAYS) EPS (Weighted Average and Diluted) (2017 - 2025)
Kaya Holdings (KAYS) recorded quarterly EPS (Weighted Average and Diluted) of -$0.06 in Q3 2025, little changed quarter-over-quarter from -$0.06 in Q2 2025, and up 40.0% on a YoY basis from -$0.04 in Q3 2024.
Kaya Holdings (KAYS) EPS (Weighted Average and Diluted) (2017 - 2025) Analysis & Trends
Kaya Holdings' EPS (Weighted Average and Diluted) history runs 9 years deep, the most recent figure standing at -$0.06 for Q3 2025.
- In Q3 2025, EPS (Weighted Average and Diluted) rose 40.0% year-over-year to -$0.06; the TTM figure through Sep 2025 stood at -$0.1 (up 9.09% YoY), while the FY2024 annual figure was -$0.07, down 800.0% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.06 for Q3 2025 at Kaya Holdings, roughly flat from -$0.06 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.5 in Q3 2022 to a low of -$0.6 in Q4 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.03 across 5 years, with a median of -$0.01 in 2024.
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) jumped 20247.09% in 2024, then tumbled 3828.46% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.18 in 2021, then plunged by 227.4% to -$0.6 in 2022, then jumped by 100.05% to $0.0 in 2023, then surged by 20247.09% to $0.06 in 2024, then tumbled by 200.0% to -$0.06 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.06 (Q3 2025), -$0.06 (Q2 2025), and -$0.04 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Kaya Holdings | - | - | 5,370.00 | -0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.06 |
| Jun 30, 2025 | -0.06 |
| Mar 31, 2025 | -0.04 |
| Dec 31, 2024 | 0.06 |
| Sep 30, 2024 | -0.10 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | -0.60 |
| Sep 30, 2022 | 0.50 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | -0.18 |
| Sep 30, 2021 | 0.06 |
| Jun 30, 2021 | 0.13 |
| Mar 31, 2021 | -0.39 |
| Dec 31, 2020 | -0.84 |